Angiodynamics, inc. approves appointment of michael e. tarnoff as class i director

The annual meeting of shareholders of angiodynamics, inc. held on october 15, 2019, approved the appointment of michael e. tarnoff, md as a class i director to serve until the 2022 annual meeting of shareholders.
ANGO Ratings Summary
ANGO Quant Ranking